(VIANEWS) – Trip.com (TCOM), Halozyme Therapeutics (HALO), The Ensign Group (ENSG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Trip.com (TCOM)
97.5% sales growth and 5.07% return on equity
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Trip.com has a trailing twelve months EPS of $1.29.
PE Ratio
Trip.com has a trailing twelve months price to earnings ratio of 27.19. Meaning, the purchaser of the share is investing $27.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.07%.
Volume
Today’s last reported volume for Trip.com is 1116040 which is 71.02% below its average volume of 3851480.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 191.3% and 145.5%, respectively.
Yearly Top and Bottom Value
Trip.com’s stock is valued at $35.07 at 20:22 EST, way below its 52-week high of $43.59 and way above its 52-week low of $19.25.
Sales Growth
Trip.com’s sales growth is 86.3% for the present quarter and 97.5% for the next.
2. Halozyme Therapeutics (HALO)
27.2% sales growth and 105.22% return on equity
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.71.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 22.52. Meaning, the purchaser of the share is investing $22.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 105.22%.
3. The Ensign Group (ENSG)
19.1% sales growth and 19.16% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $4.22.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 22.75. Meaning, the purchaser of the share is investing $22.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.16%.
Yearly Top and Bottom Value
The Ensign Group’s stock is valued at $96.01 at 20:22 EST, below its 52-week high of $104.04 and way above its 52-week low of $78.84.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 3.39B for the twelve trailing months.
Volume
Today’s last reported volume for The Ensign Group is 227907 which is 16.78% below its average volume of 273885.
Moving Average
The Ensign Group’s worth is higher than its 50-day moving average of $95.02 and above its 200-day moving average of $93.57.
4. The York Water Company (YORW)
12.5% sales growth and 10.09% return on equity
The York Water Company impounds, purifies, and distributes drinking water. It owns and operates two wastewater collection systems; five wastewater collection and treatment systems; and two reservoirs, including Lake Williams and Lake Redman, which hold approximately 2.2 billion gallons of water. The company also operates a 15-mile pipeline from the Susquehanna River to Lake Redman; and owns nine groundwater wells that supply water to customers in the Adams County. It serves customers in the fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergents, barbells, and motorcycle industries in 51 municipalities within three counties in south-central Pennsylvania. The York Water Company was incorporated in 1816 and is based in York, Pennsylvania.
Earnings Per Share
As for profitability, The York Water Company has a trailing twelve months EPS of $1.46.
PE Ratio
The York Water Company has a trailing twelve months price to earnings ratio of 27.66. Meaning, the purchaser of the share is investing $27.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.09%.
Moving Average
The York Water Company’s value is under its 50-day moving average of $41.25 and under its 200-day moving average of $43.54.
5. Middlefield Banc Corp. (MBCN)
9.4% sales growth and 10.9% return on equity
Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.39 billion at March 31, 2021. The bank operates 16 full-service banking centers and an LPL Financial® brokerage office serving Beachwood, Chardon, Cortland, Dublin, Garrettsville, Mantua, Middlefield, Newbury, Orwell, Plain City, Powell, Solon, Sunbury, Twinsburg, and Westerville. The Bank also operates a Loan Production Office in Mentor, Ohio. Additional information is available at www.middlefieldbank.bank.
Earnings Per Share
As for profitability, Middlefield Banc Corp. has a trailing twelve months EPS of $2.47.
PE Ratio
Middlefield Banc Corp. has a trailing twelve months price to earnings ratio of 10.47. Meaning, the purchaser of the share is investing $10.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.9%.
Yearly Top and Bottom Value
Middlefield Banc Corp.’s stock is valued at $25.86 at 20:22 EST, way below its 52-week high of $30.21 and way above its 52-week low of $22.09.
Volume
Today’s last reported volume for Middlefield Banc Corp. is 281 which is 99.1% below its average volume of 31446.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 30, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 3.1%.
6. Calix (CALX)
8.7% sales growth and 6.53% return on equity
Calix, Inc., together with its subsidiaries, provides cloud and software platforms, and systems and services in the United States, the Middle East, Canada, Europe, the Caribbean, and internationally. The company's cloud and software platforms, and systems and services enable communication service providers (CSPs) to provide a range of services. It provides Calix Cloud platform, a role-based analytics platform comprising Calix Marketing Cloud, Calix Support Cloud, and Calix Operations Cloud, which are configurable to display role-based insights and enable CSPs to anticipate and target new revenue-generating services and applications through mobile application. The company also offers EXOS, a carrier class smart home and business operating system that supports residential, business, and mobile subscribers; and AXOS, an operating system for access networks that allows a service provider to deliver all services on a single, elastic, converged access network that is always on, simple to operate, and quick to deploy. It offers its products through its direct sales force and resellers. Calix, Inc. was incorporated in 1999 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Calix has a trailing twelve months EPS of $0.64.
PE Ratio
Calix has a trailing twelve months price to earnings ratio of 71.45. Meaning, the purchaser of the share is investing $71.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.53%.
Moving Average
Calix’s value is higher than its 50-day moving average of $44.80 and way under its 200-day moving average of $51.55.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Calix’s EBITDA is 2.8.
Yearly Top and Bottom Value
Calix’s stock is valued at $45.73 at 20:22 EST, way below its 52-week high of $77.44 and way higher than its 52-week low of $39.61.
Volume
Today’s last reported volume for Calix is 280970 which is 53.81% below its average volume of 608322.
7. Stantec (STN)
7.9% sales growth and 13.54% return on equity
Stantec Inc. provides e professional services in the areas of infrastructure and facilities to the public and private sectors clients in Canada, the United States, and internationally. The company provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. It also offers planning and design consulting services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. In addition, it provides transportation planning and engineering services; project delivery consultancy services for mining, resources, and industrial infrastructure projects; and paleontological and archaeological services for the rail, transportation, water, and power and energy sectors. Further, the company offers environmental and cultural resource compliance services, as well as serves science and technology, commercial workplace, higher education, residential, and hospitality markets. Additionally, it is involved in the design, development, and delivery of sustainable projects; and design, construction administration, commissioning, maintenance, decommissioning, and remediation activities. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.
Earnings Per Share
As for profitability, Stantec has a trailing twelve months EPS of $1.97.
PE Ratio
Stantec has a trailing twelve months price to earnings ratio of 33.35. Meaning, the purchaser of the share is investing $33.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.54%.
Volume
Today’s last reported volume for Stantec is 70725 which is 22.95% below its average volume of 91793.
Moving Average
Stantec’s worth is under its 50-day moving average of $66.73 and way above its 200-day moving average of $59.04.
Previous days news about Stantec(STN)
- Here's how stantec (stn) gained 38% in the year-to-date period. According to Zacks on Tuesday, 26 September, "Due to pandemic-related lockdowns causing a one-year delay in operations, Stantec now expects to reach its originally established financial targets by the year 2023.", "In 2020, Stantec disbursed $68 million in dividends and conducted share repurchases of 2.05 billion shares, amounting to $78.3 million. "
8. Urban Outfitters (URBN)
6.4% sales growth and 12.28% return on equity
Urban Outfitters, Inc. engages in the retail and wholesale of general consumer products. The company operates through three segments: Retail, wholesale, and Subscription. It operates Urban Outfitters stores, which offer women's and men's fashion apparel, activewear, intimates, footwear, accessories, home goods, electronics, and beauty products for young adults aged 18 to 28; and Anthropologie stores that provide women's casual apparel, accessories, intimates, shoes, and home furnishings, as well as gifts, decorative items, and beauty and wellness products for women aged 28 to 45. The company also operates Bhldn stores, which offer heirloom quality wedding gowns, bridesmaid frocks, party dresses, assorted jewelry, headpieces, footwear, lingerie, and decorations; and Terrain stores that provide lifestyle home products, garden and outdoor living products, antiques, live plants, flowers, wellness products, and accessories. In addition, it operates Free People retail stores, which offer casual women's apparel, intimates, activewear, shoes, accessories, home products, gifts, and beauty and wellness products for young women aged 25 to 30; restaurants; and women's apparel subscription rental service under the Nuuly brand name. The company serves its customers directly through retail stores, Websites, mobile applications, catalogs and customer contact centers, franchised or third-party operated stores, and digital businesses. As of January 31, 2021, it operated 247 Urban Outfitters, 237 Anthropologie Group, and 149 Free People stores in the United States, Canada, and Europe; and 11 restaurants. The company is also involved in the wholesale of young women's contemporary casual apparel, intimates, activewear, and shoes under the Free People brand; and home goods through department and specialty stores worldwide. The company was founded in 1970 and is based in Philadelphia, Pennsylvania.
Earnings Per Share
As for profitability, Urban Outfitters has a trailing twelve months EPS of $2.36.
PE Ratio
Urban Outfitters has a trailing twelve months price to earnings ratio of 14.18. Meaning, the purchaser of the share is investing $14.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.28%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 4.95B for the twelve trailing months.
Previous days news about Urban Outfitters(URBN)
- According to Zacks on Monday, 25 September, "The forward P/E of Urban Outfitters for the current financial year is 10.92X, lower than the industry average of 12.82X. "
- According to Zacks on Tuesday, 26 September, "Here we have highlighted three other top-ranked stocks, namely American Eagle Outfitters (AEO Quick QuoteAEO – Free Report) , Urban Outfitters (URBN Quick QuoteURBN – Free Report) and Boot Barn (BOOT Quick QuoteBOOT – Free Report) ."
- Are retail-wholesale stocks lagging urban outfitters (urbn) this year?. According to Zacks on Tuesday, 26 September, "This means that Urban Outfitters is outperforming the sector as a whole this year.", "Looking more specifically, Urban Outfitters belongs to the Retail – Apparel and Shoes industry, a group that includes 43 individual stocks and currently sits at #106 in the Zacks Industry Rank. "
- According to Zacks on Monday, 25 September, "Some better-ranked stocks are BJ’s Restaurants (BJRI Quick QuoteBJRI – Free Report) , Urban Outfitters (URBN Quick QuoteURBN – Free Report) and Walmart (WMT Quick QuoteWMT – Free Report) .BJ’s Restaurants, which operates a chain of high-end casual dining restaurants in the United States, currently sports a Zacks Rank #1 (Strong Buy). "
